Tag: Harrow
Harrow ($HROW) Partners with Samsung Bioepis for U.S. Ophthalmology Biosimilar Launch
Harrow (HROW) has entered into a definitive agreement with Samsung Bioepis Co. Ltd. to secure exclusive U.S. commercial rights to Samsung Bioepis's ophthalmology biosimilar...